ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate

ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
Generic ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
Type
Formula C7H9N3O3
Weight Average: 183.1647
Monoisotopic: 183.064391169
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate

Innovators Monograph

You find simplified version here ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate



https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39721
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=84894
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443377
https://www.chemspider.com/Chemical-Structure.76584.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50143060
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=39721
https://zinc.docking.org/substances/ZINC000008078165
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/204
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID
(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE
(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide
1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE
naphthalene-1,2,4,5,7-pentol
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE
Electromyography
Cervical spine CT scan
Holter monitor (24h)
Enteroscopy
Partial thromboplastin time (PTT)
Clean catch urine sample
Total Protein and Albumin/Globulin (A/G) Ratio
DHEA Sulfate Test
Immunoelectrophoresis - urine
VDRL test
Cerumen impaction
Rash
Moderate menopausal vulvovaginal atrophy
Deep Vein Thrombosis
Infection of the outer ear
Metastatic Triple-negative Breast Cancer
Actinic Keratoses of the face
Lice of the pubic area
Hereditary tyrosinemia type-1
Recurrent Ventricular fibrillation